CJC-1295 / Ipamorelin Encourages natural growth hormone release to support energy, lean muscle, recovery, and overall vitality
Beyond pituitary research, Hexarelin has drawn substantial scientific interest for cardioprotective signaling observed in preclinical models, activity reported to persist even when growth hormone receptor pathways are pharmacologically blocked
(Heffernan et al., Endocrinology, 2001) Early human trials: promising but modest Six Phase I/II human clinical trials were conducted, enrolling roughly 900 participants total
Moreover, CWI is supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Project-ID 424778381-TRR 295 (A06) and the VERUM Foundation
These additional ingredients can help provide extra energy and support muscle recovery after intense workouts